Frontiers in Oncology | Pharmacology of Anti-Cancer Drugs

Retraction

Published on 07 Dec 2023

Retraction: Emodin interferes with AKT1-mediated DNA damage and decreases resistance of breast cancer cells to doxorubicin

in Pharmacology of Anti-Cancer Drugs

Frontiers Editorial Office

Frontiers in Oncology

doi 10.3389/fonc.2023.1337635

1,402 views

Systematic Review

Published on 06 Dec 2023

Comparative efficacy and safety of systemic therapy for advanced hepatocellular carcinoma: a systematic review and network meta-analysis

in Pharmacology of Anti-Cancer Drugs

Di Wu
Binyang Jia
Muyuan Jia
Haitao Zhao
Hong Zhao
Jinxue Zhou

Frontiers in Oncology

doi 10.3389/fonc.2023.1274754

4,557 views
5 citations

Original Research

Published on 06 Dec 2023

Assessment of anticancer properties of cumin seed (Cuminum cyminum) against bone cancer

in Pharmacology of Anti-Cancer Drugs

Rajkuberan Chandrasekaran
Muthukumar Krishnan
Sonu Chacko
Omkar Gawade
Sheik Hasan
John Joseph
Evelin George
Nemat Ali
Abdullah F. AlAsmari
Sandip Patil

Frontiers in Oncology

doi 10.3389/fonc.2023.1322875

6,441 views
12 citations

Mini Review

Published on 27 Nov 2023

The Impact of Immunotherapy on Sleep and Circadian Rhythms in Patients with Cancer

in Pharmacology of Anti-Cancer Drugs

Diwakar D. Balachandran
Lara Bashoura
Ajay Sheshadri
Ellen Manzullo
Saadia A. Faiz

Frontiers in Oncology

doi 10.3389/fonc.2023.1295267

5,047 views
7 citations

Original Research

Published on 16 Nov 2023

Long non-coding RNA PRR7-AS1 promotes osteosarcoma progression via binding RNF2 to transcriptionally suppress MTUS1

in Pharmacology of Anti-Cancer Drugs

Gu Chen-Xi
Xu Jin-Fu
Huang An-Quan
Yu Xiao
Wu Ying-Hui
Li Suo-Yuan
Shen Cong
Zou Tian-Ming
Shen Jun

Frontiers in Oncology

doi 10.3389/fonc.2023.1227789

2,757 views

Original Research

Published on 13 Nov 2023

Apatinib plus chemotherapy for non-metastatic osteosarcoma: a retrospective cohort study

in Pharmacology of Anti-Cancer Drugs

Jiaqiang Wang
Fan Zhang
Shuping Dong
Yang Yang
Fangfang Gao
Guancong Liu
Peng Zhang
Xin Wang
Xinhui Du
Zhichao Tian

Frontiers in Oncology

doi 10.3389/fonc.2023.1227461

1,493 views

Original Research

Published on 31 Oct 2023

The efficacy and safety of 5-fluorouracil/cisplatin/vincristine as a multi-agent chemotherapy regimen in gestational trophoblastic neoplasia

in Pharmacology of Anti-Cancer Drugs

Lu Wang
Qian Wang
Zhen Xu
Linli Yang
Wuliang Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1240972

1,767 views
1 citation

Case Report

Published on 24 Oct 2023

Case Report: Serum methotrexate monitoring by immunoassay: confusion by by-product, confusion by antidote

in Pharmacology of Anti-Cancer Drugs

Aditya Sharma
Philip Benoit
Frederick Lansigan
David Nierenberg

Frontiers in Oncology

doi 10.3389/fonc.2023.1237178

2,055 views
2 citations

Brief Research Report

Published on 24 Oct 2023

Acute low back pain as infusion-related reaction to monoclonal antibodies

in Pharmacology of Anti-Cancer Drugs

Pawel Majenka
Carmen Loquai
Tilman Schöning
Alexander Enk
Jessica Hassel

Frontiers in Oncology

doi 10.3389/fonc.2023.1161818

7,604 views
2 citations

Original Research

Published on 23 Oct 2023

Next-generation sequencing identifies CDKN2A alterations as prognostic biomarkers in recurrent or metastatic head and neck squamous cell carcinoma predominantly receiving immune checkpoint inhibitors

in Pharmacology of Anti-Cancer Drugs

Liqiong Xue
Wenbo Tang
Jiuli Zhou
Junli Xue
Qun Li
Xiaoxiao Ge
Fengjuan Lin
Wei Zhao
Ye Guo

Frontiers in Oncology

doi 10.3389/fonc.2023.1276009

2,937 views
10 citations

Review

Published on 23 Oct 2023

The transmembrane proteins (TMEM) and their role in cell proliferation, migration, invasion, and epithelial-mesenchymal transition in cancer

in Pharmacology of Anti-Cancer Drugs

Gloria Angelina Herrera-Quiterio
Sergio Encarnación-Guevara

Frontiers in Oncology

doi 10.3389/fonc.2023.1244740

11,654 views
15 citations

Opinion

Published on 09 Oct 2023

From bench to bedside, 2-in-1 design expedites phase 2/3 oncology drug development

in Pharmacology of Anti-Cancer Drugs

Cong Chen
Xuekui Zhang

Frontiers in Oncology

doi 10.3389/fonc.2023.1251672

2,526 views
2 citations

Review

Published on 09 Oct 2023

Natural polysaccharides exert anti-tumor effects as dendritic cell immune enhancers

in Pharmacology of Anti-Cancer Drugs

Hongtai Xiong
Xinpu Han
Liu Cai
Honggang Zheng

Frontiers in Oncology

doi 10.3389/fonc.2023.1274048

4,538 views
9 citations

Study Protocol

Published on 29 Sep 2023

Effects of imipramine on cancer patients over-expressing Fascin1; description of the HITCLIF clinical trial

in Pharmacology of Anti-Cancer Drugs

Antonio Asensi-Cantó
Edith Rodríguez-Braun
Asunción Beltrán-Videla
Ana María Hurtado
Pablo Conesa-Zamora

Frontiers in Oncology

doi 10.3389/fonc.2023.1238464

2,210 views
4 citations

Original Research

Published on 27 Sep 2023

177Lu-labeled PSMA targeting therapeutic with optimized linker for treatment of disseminated prostate cancer; evaluation of biodistribution and dosimetry

in Pharmacology of Anti-Cancer Drugs

Ayman Abouzayed
Kamila Seitova
Fanny Lundmark
Vitalina Bodenko
Maryam Oroujeni
Vladimir Tolmachev
Ulrika Rosenström
Anna Orlova

Frontiers in Oncology

doi 10.3389/fonc.2023.1221103

6,706 views
3 citations

Case Report

Published on 22 Sep 2023

Case Report: A rare case of non-small cell lung cancer with STRN-ALK fusion in a patient in very poor condition treated with first-line ensartinib

in Pharmacology of Anti-Cancer Drugs

Guo-qiang Song
Yi-zhong Li
Weiliang Kong
Guo-qiang Hu

Frontiers in Oncology

doi 10.3389/fonc.2023.1235679

2,440 views
2 citations